ATE160288T1 - Antikörper, ihre herstellung und verwendung - Google Patents

Antikörper, ihre herstellung und verwendung

Info

Publication number
ATE160288T1
ATE160288T1 AT90116234T AT90116234T ATE160288T1 AT E160288 T1 ATE160288 T1 AT E160288T1 AT 90116234 T AT90116234 T AT 90116234T AT 90116234 T AT90116234 T AT 90116234T AT E160288 T1 ATE160288 T1 AT E160288T1
Authority
AT
Austria
Prior art keywords
polypeptide
antibody
formula
acid sequence
producing
Prior art date
Application number
AT90116234T
Other languages
English (en)
Inventor
Kazuo Nakahama
Tsunehiko Fukuda
Tsutomu Kurokawa
Ken-Ichi Kuroshima
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE160288T1 publication Critical patent/ATE160288T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/48Nerve growth factor [NGF]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • C07K14/625Extraction from natural sources
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT90116234T 1989-08-28 1990-08-24 Antikörper, ihre herstellung und verwendung ATE160288T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP21871189 1989-08-28
JP13405890 1990-05-25

Publications (1)

Publication Number Publication Date
ATE160288T1 true ATE160288T1 (de) 1997-12-15

Family

ID=26468244

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90116234T ATE160288T1 (de) 1989-08-28 1990-08-24 Antikörper, ihre herstellung und verwendung

Country Status (7)

Country Link
EP (1) EP0418590B1 (de)
AT (1) ATE160288T1 (de)
CA (1) CA2024063C (de)
DE (1) DE69031726T2 (de)
DK (1) DK0418590T3 (de)
ES (1) ES2109225T3 (de)
GR (1) GR3025835T3 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1243281B (it) * 1990-06-12 1994-05-26 Fidia Spa Metodo per la determinazione quantitativa e qualitativa di polipeptidiin liquidi proteici
US5958875A (en) * 1996-03-29 1999-09-28 The Regents Of The University Of California Synthetic peptides derivatives with nerve growth factor-like neurotrophic activity
ES2357948T3 (es) 2002-10-08 2011-05-04 Rinat Neuroscience Corp. Procedimientos para tratar dolor postquirúrgico mediante la administración de un anticuerpo frente al factor de crecimiento nervioso y composiciones que contienen el mismo.
WO2005000194A2 (en) 2002-10-08 2005-01-06 Rinat Neuroscience Corp. Methods for treating post-surgical pain by administering an anti-nerve growth factor antagonist antibody and compositions containing the same
US7569364B2 (en) 2002-12-24 2009-08-04 Pfizer Inc. Anti-NGF antibodies and methods using same
CA2511598C (en) 2002-12-24 2016-09-13 Rinat Neuroscience Corp. Anti-ngf antibodies and methods using same
US9498530B2 (en) 2002-12-24 2016-11-22 Rinat Neuroscience Corp. Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same
PL379983A1 (pl) 2003-02-19 2006-11-27 Rinat Neuroscience Corp. Sposoby leczenia bólu polegające na podaniu antagonisty czynnika wzrostu nerwów i niesteroidowego leku przeciwzapalnego oraz zawierające je kompozycje
TWI503328B (zh) 2003-07-15 2015-10-11 Amgen Inc 作為選擇性神經生長因子(ngf)通道抑制劑之人類抗-ngf中和抗體
DK2206728T3 (en) 2004-04-07 2018-04-23 Rinat Neuroscience Corp METHODS OF TREATING BONE CANCER PAIN BY SUBMITTING A NERVOUS FACTOR-ANTAGONISTIC ANTIBODY
ME00226B (me) 2004-07-15 2011-02-10 Medarex Llc Humana anti-ngf neutrališuća antitijela kao selektivni inhibitori ngf signalne kaskade
EP2376122A2 (de) 2009-01-12 2011-10-19 Takeda Pharmaceutical Company Limited Wirkstoff zur prophylaxe oder behandlung von krebs

Also Published As

Publication number Publication date
JPH04128298A (ja) 1992-04-28
DK0418590T3 (da) 1998-04-20
EP0418590A1 (de) 1991-03-27
CA2024063C (en) 2002-07-16
DE69031726D1 (de) 1998-01-02
CA2024063A1 (en) 1991-03-01
ES2109225T3 (es) 1998-01-16
GR3025835T3 (en) 1998-04-30
DE69031726T2 (de) 1998-03-12
EP0418590B1 (de) 1997-11-19

Similar Documents

Publication Publication Date Title
Giri et al. Studies on the synthesis and secretion of interleukin 1. I. A 33,000 molecular weight precursor for interleukin 1.
US4636463A (en) Antibodies to human interleukin-2 induced by synthetic polypeptides
ATE88572T1 (de) Antikoerper gegen polypeptide, die gegen peptide oder proteine mit mindestens teilweise bekannter aminosaeure oder kodierender nukleotidsequenz komplementaer sind und diesbezuegliches aufbauverfahren.
LU91013I2 (fr) ReFacto (Moroctocog alfa) dans toutes ses formes couvertes par le brevet de base
ATE155141T1 (de) Glykosphingolipide mit kopplungsfähiger gruppe im sphingoidanteil, ihre herstellung und verwendung
ATE160288T1 (de) Antikörper, ihre herstellung und verwendung
AU564620B2 (en) Peptides and protein-peptide complexes
BG101408A (bg) Аналози на кератиноцитния растежен фактор
FI97299C (fi) Menetelmä kimeerisen transformoivan beta-kasvutekijän valmistamiseksi
EP0180921A3 (de) Verfahren zur Herstellung und Reinigung von Peptiden
EP0741869A1 (de) Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine
NO900758D0 (no) Fremgangsmaate for fremstilling av hybridprotein.
ATE221082T1 (de) Das polypeptid eines membran-proteins mit der funktion zur unterstützung des wachstums von prä- b zellen und sein gen
NO871573L (no) Fremgangsmaate for fremstilling av peptider.
DE3781832D1 (de) C-terminal-alpha-amidierendes enzym und verfahren zu dessen herstellung und verwendung.
DK0404750T3 (da) Vævsinhibitor for metalloproteaser
ATE99360T1 (de) Monoklonale antikoerper, die atriales natriuretisches polypeptide erkennen, ihre herstellung und verwendung.
Yanaihara et al. Synthesis of proinsulin. III. Synthesis of polypeptides related to the connecting peptide segment of bovine proinsulin
NO904129L (no) Antistoffer mot hoeykonserverte aminosyresekvenser fra immunogene forbindelser, fremgangsmaate for fremstilling av antistoffer samt anvendelse derav i immunoanalyser.

Legal Events

Date Code Title Description
EEFA Change of the company name
EEFA Change of the company name
EELA Cancelled due to lapse of time